No Data
Stocks that moved the previous day part 2: Sumitomo Mitsui Trust Bank, Urbanet, Amakaze Taiyō etc.
Stock Name <Code> Closing Price on the 27th ⇒ Change from Previous Day Sumitomo Pharma <4506> 583 -20, morgan stanley MUFG Securities continues to recommend selling. Double Scope <6619> 296 -12, a downward trend in performance outlook continues. Ricoh <7752> 1663 -89, Nomura Securities has downgraded its investment rating. Sakura Internet <3778> 4855 -05000, also aware of resistance at the 5000 yen level. japan Micro Devices <6871> 3885 -
Stocks that moved the day before part2 Abalance, Sockets, etc.
Stock name <Code> Closing price on the 27th ⇒ Change from previous day mazda motor crp <7261> 944.8 -55.1 Seeing the yen's strength in the foreign exchange market as a selling point. nissan motor co <7201> 373.5 -18.6 Continues to view negative factors such as prolonged production cuts in the United States. tokyu <9005> 1752 -80 Viewing the sale settlement cross in off-hours trading as a factor. hino motors <7205> 392.8 -15.9 Pressured by the downward trend in automobile stocks. mitsubishi motors <7211> 403.9 -20.2 Strengthening of the yen.
Shinmente HD, DELTA-P and others.
Regarding DELTA-P's 8th round of subscription rights (with exercise price adjustment clause), the number of shares to be delivered from the massive exercise starting on the 5th is 0.225 million shares. Regarding Shinmente HD's share buyback, the upper limit is 0.15 million shares (1.87% of the issued shares), with purchases expected on the ToSTNeT-3 on the 28th. Regarding CRG HD, an executive retirement compensation of 0.084 billion yen is expected to be recorded as a special loss.
Volume change rate ranking (9 o'clock) ~ DELTA-P, DyDo etc. are ranked.
In the volume change rate ranking, by comparing the average volume over the last five days with the volume on the day of distribution, one can understand trends in market interest among participants, etc. ■ Top volume change rates [As of November 27, 9:32] (Comparative analysis with the average volume over the last five days) Stock code Stock name Volume 5-day average volume Volume change rate Stock price change rate <3681> V-Cube 1,797,600 107,185.08 286.27% 0.1
DELTA-P has ranked in, recognized as a recommended treatment method in the 'Lung Cancer Treatment Guidelines 2024' for Afatinib.
DELTA-P＜4598＞ has ranked in (as of 9:32 AM). It saw a significant rise at one point. After the trading session ended the previous day, the Japan Lung Cancer Society announced that in the "Lung Cancer Treatment Guidelines 2024 Edition" published on October 20, 2024, afatinib, which is used in the clinical Phase III comparison trial of DFP-14323 conducted by the company, is stronger than osimertinib for the first-line treatment of non-small cell lung cancer (NSCLC) with positive epidermal growth factor receptor (EGFR) gene mutation uncommon mutation.
November 27th [Today's investment strategy]
[Fisco Selected Stocks] [Material Stocks] Asentec <3565> 652 yen (11/26) engages in the development of products related to virtual desktops. The performance financial estimates for the fiscal year ending January 2025 have been revised upwards. The operating profit is estimated to be 0.93 billion yen (an increase of 56.2% compared to the previous period). This estimation has been raised by about 29% from the previous forecast. The significant increase in revenue from the virtual desktop business area, which includes multiple large projects, contributed to this growth. Additionally, on September 25, a strategic partnership agreement was signed with a major U.S. software company.
No Data
No Data